BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 3083157)

  • 21. The localization of Hodgkin's disease in lymph nodes. A study with immunohistological, enzyme histochemical and rosetting techniques on frozen sections.
    Poppema S; Elema JD; Halie MR
    Int J Cancer; 1979 Nov; 24(5):532-40. PubMed ID: 93582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proliferating cell nuclear antigen (PCNA) expression in Hodgkin's disease.
    Schmid C; Sweeney E; Isaacson PG
    J Pathol; 1992 Sep; 168(1):1-6. PubMed ID: 1360494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunoperoxidase study of normal and pathologic lymphoid tissue. Value of monoclonal antibodies].
    Delsol G; Al Saati T; Caveriviere P; Voigt JJ; Ancelin E; Rigal-Huguet F
    Ann Pathol; 1984; 4(3):165-83. PubMed ID: 6383412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Florid progressive transformation of germinal centers. A syndrome affecting young men, without early progression to nodular lymphocyte predominance Hodgkin's disease.
    Ferry JA; Zukerberg LR; Harris NL
    Am J Surg Pathol; 1992 Mar; 16(3):252-8. PubMed ID: 1599017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Proliferating cells in Hodgkin's disease].
    Schmid C; Isaacson PG
    Verh Dtsch Ges Pathol; 1992; 76():151-4. PubMed ID: 1283248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunopathology of Hodgkin's disease. Characterization of Reed-Sternberg cells with monoclonal antibodies.
    Strauchen JA; Dimitriu-Bona A
    Am J Pathol; 1986 May; 123(2):293-300. PubMed ID: 3085509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical detection of Epstein-Barr virus-encoded latent membrane protein in Reed-Sternberg cells and variants of Hodgkin's disease.
    Pinkus GS; Lones M; Shintaku IP; Said JW
    Mod Pathol; 1994 May; 7(4):454-61. PubMed ID: 7520586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
    Carbone A; Gloghini A; Gruss HJ; Pinto A
    Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hodgkin's disease, lymphocyte-predominant type: immunoreactivity with B-cell antibodies.
    Coles FB; Cartun RW; Pastuszak WT
    Mod Pathol; 1988 Jul; 1(4):274-8. PubMed ID: 3266337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T and B lymphocytes in lymph nodes and spleen of patients with Hodgkin's disease.
    Berényi E; Sonkoly I; Pálóczi K; Balázs G; Szegedi G
    Neoplasma; 1979; 26(3):307-13. PubMed ID: 394011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exogenous immunoglobulin and the macrophage origin of Reed-Sternberg cells in Hodgkin's disease.
    Kadin ME; Stites DP; Levy R; Warnke R
    N Engl J Med; 1978 Nov; 299(22):1208-14. PubMed ID: 101841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
    Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
    Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Leu-3a antibody reactivity with Reed-Sternberg cells of Hodgkin's disease.
    Oka K; Mori N; Kojima M
    Arch Pathol Lab Med; 1988 Feb; 112(2):139-42. PubMed ID: 3257383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular origin of nodular lymphocyte-predominant Hodgkin's lymphoma: immunophenotypic and molecular studies.
    Chan WC
    Semin Hematol; 1999 Jul; 36(3):242-52. PubMed ID: 10462324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffuse lymphocyte-predominant Hodgkin's disease (diffuse paragranuloma). A variant of the B-cell-derived nodular type.
    Hansmann ML; Stein H; Dallenbach F; Fellbaum C
    Am J Pathol; 1991 Jan; 138(1):29-36. PubMed ID: 1987769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells.
    Marafioti T; Hummel M; Anagnostopoulos I; Foss HD; Falini B; Delsol G; Isaacson PG; Pileri S; Stein H
    N Engl J Med; 1997 Aug; 337(7):453-8. PubMed ID: 9250847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of bcl-2 major breakpoint region and JH gene rearrangement in lymphocyte predominance Hodgkin's disease. Results of Southern blot analysis and polymerase chain reaction.
    Said JW; Sassoon AF; Shintaku IP; Kurtin PJ; Pinkus GS
    Am J Pathol; 1991 Feb; 138(2):261-4. PubMed ID: 1899539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical determination of CD23 expression in Hodgkin's disease using paraffin sections.
    Rowlands DC; Hansel TT; Crocker J
    J Pathol; 1990 Mar; 160(3):239-43. PubMed ID: 2139890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The origin and clonal proliferation of malignant altered cells in Hodgkin's disease].
    Krizanac-Bengez L; Boranic M
    Lijec Vjesn; 1990; 112(1-2):50-2. PubMed ID: 2366621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T and B lymphocytes and Reed-Sternberg cells in Hodgkin's disease lymph nodes and spleens.
    Payne SV; Jones DB; Haegert DG; Smith JL; Wright DH
    Clin Exp Immunol; 1976 May; 24(2):280-6. PubMed ID: 1084241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.